Literature DB >> 30421528

Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case report.

Bénédicte Franck1, Sylvain Dulaurent1, Souleiman El Balkhi1, Caroline Monchaud1, Nicolas Picard1, Sylvain Couderc1, Pierre Marquet1, Franck Saint-Marcoux1, Jean-Baptiste Woillard1.   

Abstract

A 67-year-old man was admitted to the emergency department about 5 h after deliberate self-poisoning with 300 mg of Apixaban. The clinical examination did not show any organ dysfunctions or haemorrhagic signs, and the patient's life was not in danger. The first analysis, upon admission, showed a concentration of 2655 μg l-1 of Apixaban. The Cmax was observed 17 h after the intake (3654 μg l-1 ), about four times the classical Tmax value (median [range]: 4 h [2-4]). The Apixaban was then eliminated following a first order elimination with a calculated half-life of 10.8 h. The anti-Xa activity seems to be linearly related to concentration up to 4000 μg l-1 . This report suggests that the use of activated charcoal should be effective up to 17 h after a massive intake.
© 2018 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30421528      PMCID: PMC6303243          DOI: 10.1111/bcp.13790

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  Anti-Xa activity in apixaban overdose: a case report.

Authors:  James Barton; Anselm Wong; Andis Graudins
Journal:  Clin Toxicol (Phila)       Date:  2016-07-20       Impact factor: 4.467

2.  Apixaban Auto-intoxication: Toxicokinetics and Coagulation Tests.

Authors:  L Mast; R J Verheul; R Reijnen; R C J M van Rossen; J W P M Overdiek; E B Wilms
Journal:  Thromb Haemost       Date:  2017-11-30       Impact factor: 5.249

3.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Transporters.

Authors:  Stephen Ph Alexander; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

4.  Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case report.

Authors:  Bénédicte Franck; Sylvain Dulaurent; Souleiman El Balkhi; Caroline Monchaud; Nicolas Picard; Sylvain Couderc; Pierre Marquet; Franck Saint-Marcoux; Jean-Baptiste Woillard
Journal:  Br J Clin Pharmacol       Date:  2018-11-12       Impact factor: 4.335

5.  The X factor: Lack of bleeding after an acute apixaban overdose.

Authors:  Scott M Leikin; Hina Patel; Katherine L Welker; Jerrold B Leikin
Journal:  Am J Emerg Med       Date:  2016-11-12       Impact factor: 2.469

6.  Investigating the enteroenteric recirculation of apixaban, a factor Xa inhibitor: administration of activated charcoal to bile duct-cannulated rats and dogs receiving an intravenous dose and use of drug transporter knockout rats.

Authors:  Donglu Zhang; Charles E Frost; Kan He; A David Rodrigues; Xiaoli Wang; Lifei Wang; Theunis C Goosen; W Griffith Humphreys
Journal:  Drug Metab Dispos       Date:  2013-02-05       Impact factor: 3.922

7.  Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects.

Authors:  Charles Frost; Sunil Nepal; Jessie Wang; Alan Schuster; Wonkyung Byon; Rebecca A Boyd; Zhigang Yu; Andrew Shenker; Yu Chen Barrett; Rogelio Mosqueda-Garcia; Frank Lacreta
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

Review 8.  Activated charcoal for acute overdose: a reappraisal.

Authors:  David N Juurlink
Journal:  Br J Clin Pharmacol       Date:  2015-11-09       Impact factor: 4.335

9.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.

Authors:  Simon D Harding; Joanna L Sharman; Elena Faccenda; Chris Southan; Adam J Pawson; Sam Ireland; Alasdair J G Gray; Liam Bruce; Stephen P H Alexander; Stephen Anderton; Clare Bryant; Anthony P Davenport; Christian Doerig; Doriano Fabbro; Francesca Levi-Schaffer; Michael Spedding; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

10.  Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects.

Authors:  Xiaoli Wang; Sabiha Mondal; Jessie Wang; Giridhar Tirucherai; Donglu Zhang; Rebecca A Boyd; Charles Frost
Journal:  Am J Cardiovasc Drugs       Date:  2014-04       Impact factor: 3.571

View more
  2 in total

1.  Self-poisoning with 60 tablets of Apixaban, a pharmacokinetics case report.

Authors:  Bénédicte Franck; Sylvain Dulaurent; Souleiman El Balkhi; Caroline Monchaud; Nicolas Picard; Sylvain Couderc; Pierre Marquet; Franck Saint-Marcoux; Jean-Baptiste Woillard
Journal:  Br J Clin Pharmacol       Date:  2018-11-12       Impact factor: 4.335

2.  Accidental apixaban intoxication in a 23-month-old child: a case report.

Authors:  Manon Launay; Yara Nasser; Isabelle Maubert; Anne-Cécile Chaux; Xavier Delavenne
Journal:  BMC Pediatr       Date:  2020-12-05       Impact factor: 2.125

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.